Cite
HARVARD Citation
Iavarone, M. et al. (n.d.). AGT gene polymorphisms predict early dose modification of sorafenib for dermatological adverse events: towards tailored medicine for patients with hepatocellular carcinoma. Digestive and liver disease. pp. e38-. [Online].